Postgrad LIVE! Study Fairs

Southampton | Bristol

University of Leeds Featured PhD Programmes
Birkbeck, University of London Featured PhD Programmes
University of West London Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
University of Leeds Featured PhD Programmes

Queen Mary University of London and A*STAR PhD Studentship: Investigating Immune micro-environment in pancreatic cancer

  • Full or part time
  • Application Deadline
    Friday, March 01, 2019
  • Funded PhD Project (European/UK Students Only)
    Funded PhD Project (European/UK Students Only)

Project Description

This PhD programme is a collaboration between A*STAR and Queen Mary University of London (QMUL) to provide research opportunities for PhD students at A*STAR Research Institutes. Under this programme, PhD students from overseas universities will spend one to two years at A*STAR Research Institutes under the joint supervision of staff of the A*STAR Research Institutes and QMUL.

Our work on pancreatic cancer micro-environment and immune cells has uncovered that the tertiary lymphoid structures (TLS) may be critical in mounting anti-tumour immune response in pancreatic ductal adenocarcinoma (PDAC).

With help of key researchers at A*STAR, we aim to understand the manner in which cellular immune response if modulated in PDAC.

We will study this using human samples via the Pancreatic Cancer Research Fund Tissue Bank (PCRFTB), and murine models of PDAC as well as novel in vitro assays to understand the cell-cell interactions between different immune cells such as dendritic cells, follicular dendritic cells, and T- and B-cells. We aim to achieve the first description of global immune infiltrate in human PDAC using a sample size adequate for determining the impact of immune cells and TLS in PDAC.

We will determine the impact of differential immune infiltrate on the overall prognosis including co-variates such as tumour stage, tumour burden, presence of systemic inflammation, and other conjunct therapies.

Using a combination of in vivo models with no spontaneous orthotopic and transgenic (KPC) mice as well as human samples, we will determine the therapeutic benefit of forming an immunogenic response in a small proportion of patients where there is survival benefit.

By integrating the analysis from human and murine samples, therapeutic experimental and in vitro analyses we will elucidate the mechanisms involved in cellular immune response in pancreatic cancer. The applicant will have opportunity to work with an inter-disciplinary team in the UK lab comprised of immunologist, cancer biologist, bio-informactician, statistics experts and clinical trialists.

Qualifications:
All applicants should hold a masters level degree at first /distinction level in Cancer biology or Immunology (or a related discipline). Applicants should have a good knowledge of English and ability to express themselves clearly in both speech and writing. The successful candidate must be strongly motivated for doctoral studies, must have demonstrated the ability to work independently and to perform critical analysis.

Candidates are asked to possess fundamental knowledge and skills in two or more of the following areas:
- Excellent background in cancer immunology. Good knowledge of in vivo and in vitro techniques, such as histological analysis and FACS would be vital.
- Prior experience/education in laboratory techniques such as histological analysis would be helpful.
- Hands on experience using human samples would be very vital.

For more information, including details of how to apply please see:
https://www.bci.qmul.ac.uk/en/study-with-us/postgraduate-research/qmul-a-star-phd-studentship

Funding Notes

UK / EU nationalities are eligible to apply for this studentship.
We offer a 4 year fully funded PhD studentship, with a bursary ~£16.5K/year (during the time in UK) supported by the School of Medicine and Dentistry at the Queen Mary University of London, UK (View Website) as well as monthly stipend of S$2,500 (during the time in Singapore) and the corresponding allowance supported by A*STAR Research Institutes:
View Website

How good is research at Queen Mary University of London in Clinical Medicine?

FTE Category A staff submitted: 144.11

Research output data provided by the Research Excellence Framework (REF)

Click here to see the results for all UK universities

Email Now

Insert previous message below for editing? 
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need.
Why not add a message here
* required field
Send a copy to me for my own records.

Your enquiry has been emailed successfully





FindAPhD. Copyright 2005-2019
All rights reserved.